Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
MeSH Number(s)
C04.697.655
C23.550.727.655
Concept/Terms
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in Harvard Catalyst Profiles by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 20 | 24 | 44 |
1995 | 16 | 28 | 44 |
1996 | 21 | 50 | 71 |
1997 | 10 | 43 | 53 |
1998 | 15 | 39 | 54 |
1999 | 24 | 37 | 61 |
2000 | 21 | 54 | 75 |
2001 | 24 | 32 | 56 |
2002 | 23 | 37 | 60 |
2003 | 36 | 39 | 75 |
2004 | 40 | 36 | 76 |
2005 | 44 | 45 | 89 |
2006 | 44 | 51 | 95 |
2007 | 54 | 70 | 124 |
2008 | 64 | 61 | 125 |
2009 | 51 | 57 | 108 |
2010 | 77 | 64 | 141 |
2011 | 90 | 79 | 169 |
2012 | 111 | 65 | 176 |
2013 | 145 | 95 | 240 |
2014 | 138 | 59 | 197 |
2015 | 115 | 94 | 209 |
2016 | 116 | 83 | 199 |
2017 | 129 | 98 | 227 |
2018 | 143 | 94 | 237 |
2019 | 139 | 135 | 274 |
2020 | 133 | 170 | 303 |
2021 | 89 | 220 | 309 |
2022 | 22 | 252 | 274 |
2023 | 12 | 238 | 250 |
2024 | 3 | 48 | 51 |
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Multimodality Imaging of Postmastectomy Breast Reconstruction Techniques, Complications, and Tumor Recurrence. Radiographics. 2024 May; 44(5):e230070.
-
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin. Commun Biol. 2024 Apr 08; 7(1):426.
-
CGE24-096: Impact of Somatic Mutations on Outcomes of Salvage Radiation and Hormonal Therapy for Prostate Cancer Recurrence After Prostatectomy. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5).
-
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer. Clin Cancer Res. 2024 Apr 01; 30(7):1240-1247.
-
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer. Int J Gynecol Cancer. 2024 Apr 01; 34(4):469-477.
-
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study. Nat Commun. 2024 Mar 27; 15(1):2691.
-
Long-term outcomes of PGA-TMC absorbable synthetic scaffold in both clean and contaminated ventral hernia repairs. Surg Endosc. 2024 Apr; 38(4):2231-2239.
-
Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis. Front Immunol. 2024; 15:1331994.
-
Surgical margins and outcomes for eyelid melanoma: a systematic review and meta-analysis. Arch Dermatol Res. 2024 Mar 15; 316(4):106.
-
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma. N Engl J Med. 2024 Apr 11; 390(14):1290-1298.